Clinical Trial Update: A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C) [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial (COHORT-C) comparing niraparib to platinum-taxane chemotherapy in homologous recombination–deficient advanced ovarian cancer was ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Niraparib (Niraparib)
• Platinum-Taxane doublet chemotherapy

Snippet

Sponsor: Tesaro, Inc. | Conditions: Ovarian Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2025-07-15